Valeo Pharma Inc.

Feb 17, 2021

Valeo Pharma's Hesperco(TM) Capsules at the Core of Montreal Heart Institute's Hesperidin Coronavirus Clinical Trial

Jan 18, 2021

Valeo Pharma Announces Major Addition to its Senior Management Team

Jan 12, 2021

Valeo Pharma Highlights MDBriefCase Newsletter Comparing Hesperidin and Vitamin C for COVID-19

Dec 29, 2020

Valeo Pharma Announces DTC Eligibility for the Trading of Its Shares on the US OTCQB Market

Dec 09, 2020

Valeo Pharma Announces Health Canada Approval for Redesca(TM) and Redesca Hp(TM)

Nov 12, 2020

Valeo Pharma announces Amikacin approval in CANADA and U.S. launch of Ethacrynate Sodium

Oct 13, 2020

Valeo Pharma Announces That Hesperco(TM) Has Started Shipping

Sep 23, 2020

Valeo Pharma to Report Third Quarter 2020 Results and Hold Investors Conference Call / Webcast

Sep 23, 2020

Valeo Pharma Begins Trading on the U.S. OTCQB Market